Ignite Creation Date:
2024-05-11 @ 8:30 AM
Last Modification Date:
2024-10-26 @ 3:29 PM
Study NCT ID:
NCT06409312
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-05-16
First Post:
2024-05-07
Brief Title:
Digital Healthcare App After Total Hip Arthroplasty
Sponsor:
Schulthess Klinik
Organization:
Schulthess Klinik
Study Overview
Official Title:
Assessing the Feasibility of a Digital Healthcare App for Patient Rehabilitation After Total Hip Arthroplasty
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study examines the effectiveness of rehabilitation after hip replacement surgery using a specialised app called Akina Cloud Medical professionals at the Schulthess Clinic will provide detailed information about the study Participants must meet certain eligibility requirements There will be time for consideration before enrolment A demonstration of how to use the app will be provided upon agreement Participants will be shown how to set up their profile and interact with a real therapist who will provide feedback The initial 30-minute introduction is scheduled to take place a few days after surgery while still in hospital Participants will be asked to complete several questionnaires The rehabilitation process involves using the app for at least 12 weeks at least three times a week for 20-30 minutes per session Direct communication with the therapist via the app is available for any queries Follow-up questionnaires will be emailed at 6 and 12 weeks after training and again at 26 weeks to assess progress and feedback on the use of the app Each session with the app lasts about 20 minutes and the questionnaire takes about 30 minutes to complete
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None